Orion (Finland) Overview
- Year Founded
-
1917
- Status
-
Public
- Employees
-
4,174
- Stock Symbol
-
ORNAV
- Investments
-
7
- Share Price
-
$111.53
- (As of Tuesday Closing)
Orion (Finland) General Information
Description
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
Contact Information
Website
www.orionpharma.comCorporate Office
- Orionintie 1A
- 02200 Espoo
- Finland
Corporate Office
- Orionintie 1A
- 02200 Espoo
- Finland
Orion (Finland) Stock Performance
As of 17-Nov-2026, Orion (Finland)’s stock price is $111.53. Its current market cap is $15.7B with 140M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $111.53 | $113.33 | $67.93 - $115.26 | $15.7B | 140M | 7.08K | $5.44 |
Orion (Finland) Financials Summary
As of 30-Sep-2026, Orion (Finland) has a trailing 12-month revenue of $2.53B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 13,206,708 | 10,631,458 | 6,331,673 | 6,234,467 |
| Revenue | 2,529,134 | 2,131,368 | 1,669,029 | 1,287,237 |
| EBITDA | 963,529 | 768,623 | 500,795 | 346,805 |
| Net Income | 765,316 | 564,341 | 356,984 | 234,594 |
| Total Assets | 2,306,480 | 2,360,749 | 1,695,196 | 1,590,228 |
| Total Debt | 142,319 | 358,611 | 340,579 | 221,191 |
Orion (Finland) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Orion (Finland) Comparisons
Industry
Financing
Details
Orion (Finland) Competitors (1)
One of Orion (Finland)’s competitors is Ever Pharma, a Corporation company based in Unterach, Austria.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ever Pharma | Corporation | Unterach, Austria |
Orion (Finland) Patents
Orion (Finland) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-242852-S | Packaging for foodstuffs | Active | 05-Aug-2025 | ||
| US-D1141940-S1 | Packaging | Active | 17-Jun-2025 | ||
| WO-2026180566-A1 | Antigen binding molecules | Pending | 28-Feb-2025 | ||
| WO-2026132683-A1 | Piperidine derivatives useful as gpr183 antagonists | Pending | 20-Dec-2024 | ||
| WO-2026136294-A1 | Probiotic compositions of p. hiranonis and methods | Pending | 16-Dec-2024 | A61P1/12 |
Orion (Finland) Signals
Orion (Finland) Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Orion (Finland) Investments & Acquisitions (7)
Orion (Finland)’s most recent deal was a Early Stage VC with Eion for . The deal was made on 25-Sep-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Eion | 25-Sep-2024 | Early Stage VC | Environmental Services (B2B) | ||
| V.M.D. | 15-Jun-2022 | Merger/Acquisition | Other Commercial Products | ||
| Knit Finance | 07-May-2021 | Seed Round | Financial Software | ||
| AffaMed Therapeutics | 30-Mar-2021 | PE Growth/Expansion | Drug Discovery | ||
| PharmaService (Finland) | 26-Nov-2010 | Secondary Transaction - Private | Other Devices and Supplies |
Orion (Finland) ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
20.49 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Orion (Finland) Exits (4)
Orion (Finland)’s most recent exit was on 25-Sep-2024 from Eion. The exit was categorized as with 11 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Eion | 25-Sep-2024 | Completed |
|
||
| PharmaService (Finland) | 26-Nov-2010 | Completed |
|
||
| Kronans Droghandel | 01-Jul-2002 | Completed |
|
||
| Kronans Droghandel | Corporate | Completed |
Orion (Finland) Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Orion Pharma (UK) | London, United Kingdom | 1988 | |
| Orion Pension Fund | Espoo, Finland |
Orion (Finland) FAQs
-
When was Orion (Finland) founded?
Orion (Finland) was founded in 1917.
-
Where is Orion (Finland) headquartered?
Orion (Finland) is headquartered in Espoo, Finland.
-
What is the size of Orion (Finland)?
Orion (Finland) has 4,174 total employees.
-
What industry is Orion (Finland) in?
Orion (Finland)’s primary industry is Pharmaceuticals.
-
Is Orion (Finland) a private or public company?
Orion (Finland) is a Public company.
-
What is Orion (Finland)’s stock symbol?
The ticker symbol for Orion (Finland) is ORNAV.
-
What is the current stock price of Orion (Finland)?
As of 17-Nov-2026 the stock price of Orion (Finland) is $111.53.
-
What is the current market cap of Orion (Finland)?
The current market capitalization of Orion (Finland) is $15.7B.
-
What is Orion (Finland)’s current revenue?
The trailing twelve month revenue for Orion (Finland) is $2.53B.
-
Who are Orion (Finland)’s competitors?
Ever Pharma is a competitor of Orion (Finland).
-
What is Orion (Finland)’s annual earnings per share (EPS)?
Orion (Finland)’s EPS for 12 months was $5.44.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process